| Resveratrol for Alzheimer's Disease (NCT01504854) | Alzheimer's Disease Cooperative Study (ADCS) | 2012-05-01 |
| A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease (NCT01561053) | Instituto Grifols, S.A. | 2012-04-19 |
| Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study (NCT01729598) | Gregory Jicha, 323-5550 | 2012-04-01 |
| Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease (NCT01560585) | University Hospitals Cleveland Medical Center | 2012-04-01 |
| Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease (NCT00412048) | University Hospital, Strasbourg, France | 2012-04-01 |
| Venlafaxine for Depression in Alzheimer's Disease (DIADs-3) (NCT01609348) | Johns Hopkins University | 2012-04-01 |
| Early Counseling and Support for Alzheimer's Disease Caregivers (NCT02685787) | Azienda Sanitaria Locale N.1 dell'Umbria | 2012-04-01 |
| Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly (NCT01661894) | Duke-NUS Graduate Medical School | 2012-04-01 |
| Retinal Neurodegenerative Signs in Alzheimer's Diseases (NCT01555827) | University Hospital, Bordeaux | 2012-03-12 |
| Deep Brain Stimulation for the Treatment of Alzheimer's Disease (NCT01559220) | Ali Rezai, MD | 2012-03-01 |
| Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors (NCT01529619) | Novartis Pharmaceuticals | 2012-03-01 |
| Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease (NCT01561430) | Eli Lilly and Company | 2012-03-01 |
| Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease (NCT01547689) | Affiliated Hospital to Academy of Military Medical Sciences | 2012-03-01 |
| Physical Training and Cognitive Activity on the Mild Cognitive Impairment (MCI) Patient (NCT01553929) | Centre Hospitalier Universitaire de Nice | 2012-03-01 |
| Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors (NCT01549834) | AbbVie (prior sponsor, Abbott) | 2012-03-01 |
| Blood-brain Barrier Permeability in Alzheimer's Disease (NCT01574456) | Maastricht University Medical Center | 2012-03-01 |
| A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535]) (NCT01537757) | Merck Sharp & Dohme LLC | 2012-03-01 |
| The Primary Care - Dementia Assessment and Treatment Algorithm (NCT01548053) | Queen's University | 2012-03-01 |
| Seizure Activity in Alzheimer's Disease (NCT01554683) | Beth Israel Deaconess Medical Center | 2012-02-01 |
| Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease (NCT01527916) | AbbVie (prior sponsor, Abbott) | 2012-02-01 |
| Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease (NCT01492374) | Bristol-Myers Squibb | 2012-02-01 |
| Phase 3 IGIV, 10% in Alzheimer´s Disease (NCT01524887) | Baxalta now part of Shire | 2012-01-23 |
| Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients (NCT01485302) | Sanofi | 2012-01-01 |
| The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's Disease (NCT01819545) | Shanghai Mental Health Center | 2012-01-01 |
| Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study (NCT01624389) | Chang Gung Memorial Hospital | 2012-01-01 |
| Experimental Study to Validate the "Therapeutic Game" CONEM-BETA (NCT01652222) | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | 2012-01-01 |
| Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease (NCT01538212) | Cerecin | 2012-01-01 |
| Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's Disease (NCT01481558) | University of Sao Paulo | 2012-01-01 |
| NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease (NCT01600469) | Chang Gung Memorial Hospital | 2012-01-01 |
| Central and Systemic Inflammation in Alzheimer's Disease (NCT01775696) | Assistance Publique - Hôpitaux de Paris | 2011-12-08 |
| A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1]) (NCT01496170) | Merck Sharp & Dohme LLC | 2011-12-01 |
| Retrieval of Patient Information After Discontinuation (NCT01658722) | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 2011-12-01 |
| A Non-drug Methods Study in Participants With Alzheimer's Disease (NCT01459016) | Eli Lilly and Company | 2011-12-01 |
| Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005A (NCT01568086) | Affiris AG | 2011-12-01 |
| Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120) (NCT01595646) | Wake Forest University Health Sciences | 2011-11-01 |
| A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery (NCT01592552) | Sanguine Biosciences | 2011-11-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects (NCT01467726) | Alfasigma S.p.A. | 2011-11-01 |
| Escitalopram for the Treatment of Depression in Alzheimer's Disease (NCT01841125) | Konkuk University Medical Center | 2011-11-01 |
| EEG Objectification in Neuropsychiatry (NCT01476228) | Hadassah Medical Organization | 2011-11-01 |
| A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease (NCT01482845) | Abbott | 2011-11-01 |
| Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center (NCT01465360) | Exonhit | 2011-11-01 |
| Endothelial Facilitation in Alzheimer's Disease (NCT01439555) | University of Massachusetts, Worcester | 2011-11-01 |
| A Safety Study of TTP4000 in Subjects With Alzheimer's Disease (NCT01548430) | vTv Therapeutics | 2011-10-01 |
| Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD) (NCT01466088) | Targacept Inc. | 2011-10-01 |
| Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45). (NCT01746706) | Assistance Publique Hopitaux De Marseille | 2011-10-01 |
| Study of Magnetic Fields to Treat Alzheimer's Disease (NCT01313806) | pico-tesla Magnetic Therapies, LLC | 2011-09-01 |
| Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients. (NCT01436045) | HealthPartners Institute | 2011-09-01 |
| Minocycline in Patients With Alzheimer's Disease (NCT01463384) | Huntington Medical Research Institutes | 2011-09-01 |
| Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil (NCT01478633) | Janssen Pharmaceutical K.K. | 2011-09-01 |
| A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease (NCT01397578) | Genentech, Inc. | 2011-08-31 |
| The Prevalence of Vitamin D Deficiency in Patients With Alzheimer's Disease (NCT01420315) | Saglik Bilimleri Universitesi Gulhane Tip Fakultesi | 2011-08-01 |
| VI-1121 for the Treatment Alzheimer's Disease (NCT01428362) | VIVUS LLC | 2011-08-01 |
| Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP) (NCT01421056) | Chiesi Farmaceutici S.p.A. | 2011-07-01 |
| A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease (NCT01399125) | Novartis Pharmaceuticals | 2011-07-01 |
| 3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease (NCT01374438) | Metabolic Solutions Development Company | 2011-07-01 |
| Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease (NCT01357629) | Affiris AG | 2011-07-01 |
| Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease (NCT01369225) | Pfizer | 2011-07-01 |
| Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease (NCT01388478) | Virginia Commonwealth University | 2011-07-01 |
| A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil (NCT01406145) | Astellas Pharma Inc | 2011-06-16 |
| Oculomotor Testing in the Differential Diagnosis of Dementia (NCT01577394) | Assistance Publique - Hôpitaux de Paris | 2011-06-01 |
| Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease (NCT01569516) | Changchun Huayang High-tech Co., Ltd | 2011-06-01 |
| Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine (NCT01380288) | Dong-A University | 2011-06-01 |
| Vagus Somatosensory Evoked Potentials and Near-infrared Spectroscopy in the Early Diagnosis of Dementia (NCT02224326) | University of Wuerzburg | 2011-06-01 |
| Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease (NCT01397539) | Biogen | 2011-06-01 |
| PRISM Registry: Pseudobulbar Affect Registry Series (NCT01366027) | Avanir Pharmaceuticals | 2011-05-01 |
| Cognition And Neocortical Volume After Stroke (NCT02205424) | The Florey Institute of Neuroscience and Mental Health | 2011-05-01 |
| NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support) (NCT01370954) | Pamlab, Inc. | 2011-05-01 |
| iCare Stress Management e-Training for Dementia Family Caregivers (NCT01378195) | Photozig, Inc. | 2011-05-01 |
| Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET (NCT01202994) | University of Utah | 2011-05-01 |
| A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY) (NCT01343966) | Genentech, Inc. | 2011-04-30 |
| Comparative Research of Alzheimer's Disease Drugs (NCT01362686) | Indiana University | 2011-04-01 |
| Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease (NCT01324518) | Orion Corporation, Orion Pharma | 2011-04-01 |
| Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients (NCT01350362) | Noscira SA | 2011-04-01 |
| Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days (NCT01547169) | University of Washington | 2011-03-01 |
| Effect of Exercises Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease (NCT02074215) | National Taiwan University Hospital | 2011-03-01 |
| Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease (NCT01409915) | University of Colorado, Denver | 2011-03-01 |
| A Study of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test (NCT01322373) | Orasi Medical, Inc. | 2011-03-01 |
| Computerized Personal Interventions for Alzheimer's Patients (NCT01329484) | Shaare Zedek Medical Center | 2011-03-01 |
| Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 (NCT01303744) | CERESPIR | 2011-03-01 |
| Use of Autobiographical and Interest Assessment for a Better Stimulation of Patients in Nursing Home (NCT01314131) | Association Recherche Méthodologie Evaluation Psychiatrique | 2011-03-01 |
| Exercise Trial for Alzheimer's Disease (NCT01311492) | Pennington Biomedical Research Center | 2011-03-01 |
| Imaging of Cognition, Learning, and Memory in Aging (NCT01297114) | Yaakov Stern | 2011-03-01 |
| Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease (NCT01227564) | Pfizer | 2011-02-01 |
| Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) (NCT01565382) | Avid Radiopharmaceuticals | 2011-02-01 |
| Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease (NCT01354691) | Avraham Pharmaceuticals Ltd | 2011-02-01 |
| Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects (NCT01258452) | CERESPIR | 2011-02-01 |
| Safety and Tolerability of Etanercept in Alzheimer's Disease (NCT01068353) | University of Southampton | 2011-01-01 |
| Evaluation of Physician Training Methods to Read Florbetapir-PET Scans (NCT01565369) | Avid Radiopharmaceuticals | 2011-01-01 |
| Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease (NCT01284387) | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 2011-01-01 |
| Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease (NCT01127633) | Eli Lilly and Company | 2010-12-01 |
| Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease (NCT01251718) | Eisai Co., Ltd. | 2010-12-01 |
| A Safety Study of LY2886721 Multiple Doses in Healthy Subjects (NCT01227252) | Eli Lilly and Company | 2010-12-01 |
| Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer Patients (NCT01504958) | Beth Israel Deaconess Medical Center | 2010-12-01 |
| Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease (NCT01254773) | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 2010-12-01 |
| Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly Cohort (NCT01294540) | Eisai Inc. | 2010-12-01 |
| The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease (NCT01329536) | Avera McKennan Hospital & University Health Center | 2010-12-01 |
| Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease (NCT01238991) | Pfizer | 2010-12-01 |
| A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease (NCT01224106) | Hoffmann-La Roche | 2010-11-30 |
| A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease (NCT01255163) | National Institute on Aging (NIA) | 2010-11-21 |
| Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease (NCT01481961) | Pierre Vandel, MD PhD | 2010-11-01 |